Join Our Vision!


Current open positions 

Taliaz is a health-technology start-up that is revolutionizing the treatment and management of mental health disorders with PREDICTIX, the world’s first decision-support and treatment validation platform.


Taliaz is hiring!

Taliaz has developed Predictix, a game-changing, Artificial-Intelligence algorithm to personalize medicine. Its proprietary, platform goes beyond existing genetic testing solutions, to enable deep-data analysis of the highly-complex role of each patients’ unique biological background and environment in driving behaviors, for optimized treatment.   

Taliaz’s first solution, Predictix Antidepressant, already available in the UK and Israeli markets, is a clinical software tool to empower doctors to better treat depression. Developed from the world’s largest prospective study on depression therapies involving thousands of patients, doctors receive a personalized report with predictive information about antidepressant drugs matched to patients’ genetic makeup and health record. 


Tel: +972 (0)77 335 2506

Fax: +972 (0)3 650 5594


2 Prof. Yehezkel Kaufmann St.

(15th Floor), Tel Aviv-Yafo, Israel

  • LinkedIn
  • Twitter
  • Facebook

Disclaimer: Taliaz is developing the PREDICTIX Genetics and PREDICTIX Digital products. PREDICTIX Genetics Antidepressant and PREDICTIX Digital Antidepressant are currently available for commercial use in the EU and Israel. Outside of the EU and Israel, PREDICTIX Genetics & Digital products are currently limited by law for investigational use only.

Copyright © 2020 PREDICTIX by TALIAZ Ltd. All Rights Reserved